2022. Short-term Outcomes of the Use of Intraventricular Ribavirin in Filipino Patients with Subacute Sclerosing Panencephalitis. Acta Medica Philippina. 56, 9 (May 2022). DOI:https://doi.org/10.47895/amp.v56i9.5341.